System can rapidly and accurately detect tumor margins during breast cancer surgery

November 30, 2018

Scientists from the RIKEN Cluster for Pioneering Research (CPR), Osaka University, and collaborators have developed a new rapid and inexpensive way to accurately detect the margins between cancer and non-cancerous tissue during breast surgery. Their system is noteworthy in that it can detect the morphology of the cells, differentiating between cells that are more or less dangerous.

Today, breast-conserving surgery is widely used for the treatment of breast cancer. As a result, finding exactly where a tumor ends and where the healthy tissue begins is an important--but difficult--task for cancer surgeons. Patients hope to keep as much of their healthy breast as possible, but not removing enough can lead to recurrences. At present, the most popular method for finding boundaries is frozen section analysis but it is time-consuming and labor-intensive. For the frozen section analysis, tissues have to be taken and examined during the surgery by a pathologist in a process that can take as long as a half hour.

Now, however, in a study published in Advanced Science, scientists have developed a way to sensitively, selectively, and quickly detect surgical margins by using a "click-to-sense" acrolein probe that conjugates with the components of live breast cancer cells. Using resected stumps from patients during surgery, they found that the method is both sensitive, in that in is almost equal to pathology in identifying tumor tissue, and selective, in that it does not often identify non-tumor tissue inaccurately as tumors.

The secret to the method is acrolein, a highly toxic chemical that is generated in tumor cells and other cells undergoing oxidative stress. Previously, the group had developed an azide probe that "clicks" to acrolein and then can be made to glow, giving visual clues on the concentration of acrolein in cells.

Using this method, they analyzed tissues in real-time from a group of patients who had given consent to participating in the study. They took 30 stumps of cancerous tissue and 30 of normal tissue resected from patients during surgery, and examined them using the fluorescence-based acrolein probe. Using the optimal amount of the probe, they found that both the sensitivity and selectivity were 97 percent. According to Shinzaburo Noguchi of Osaka University, whose team performed the surgeries, "We were quite surprised that the probe developed by RIKEN could so accurately and rapidly identify tissues. This method seems to have the potential to be a great advance for breast-conserving breast cancer surgery."

Looking to the future, Katsunori Tanaka of RIKEN, whose team developed the probe, says, "We are also excited that our system has been able to identify other types of cancer cells as well. In the current study we focused on breast cancer, which has a high prevalence, and we are planning to move it into clinical trials now and to launch studies with other types of cancer as well."
-end-


RIKEN

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.